The global market for Wearable Neuromodulation Device was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

A Wearable Neuromodulation Device is a portable device used to deliver electrical or electromagnetic stimulation to specific areas of the body or brain for therapeutic purposes. It is designed to be worn on the body, typically as a headband, wristband, or patch, and delivers targeted stimulation to modulate neural activity.

North American market for Wearable Neuromodulation Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Wearable Neuromodulation Device is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Wearable Neuromodulation Device include Nexalin, Cefaly, Theranica Bio-Electronics Ltd., Neurolief Inc., eNeura Inc., Avation Medical, NeuroMetrix, Softeq Development, Cala Health, Inc., Neurotherapeutics Ltd, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Wearable Neuromodulation Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Wearable Neuromodulation Device.

The Wearable Neuromodulation Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Wearable Neuromodulation Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Wearable Neuromodulation Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Wearable Neuromodulation Device Market Report

Report Metric	Details
Report Name	Wearable Neuromodulation Device Market
Segment by Type	Head Mounted Hand-worn Leg-worn Foot-worn
Segment by Application	Hospital Clinic Residential Nursing Home Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Nexalin, Cefaly, Theranica Bio-Electronics Ltd., Neurolief Inc., eNeura Inc., Avation Medical, NeuroMetrix, Softeq Development, Cala Health, Inc., Neurotherapeutics Ltd, BlueWind Medical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Wearable Neuromodulation Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Wearable Neuromodulation Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Wearable Neuromodulation Device Market report?

Ans: The main players in the Wearable Neuromodulation Device Market are Nexalin, Cefaly, Theranica Bio-Electronics Ltd., Neurolief Inc., eNeura Inc., Avation Medical, NeuroMetrix, Softeq Development, Cala Health, Inc., Neurotherapeutics Ltd, BlueWind Medical

What are the Application segmentation covered in the Wearable Neuromodulation Device Market report?

Ans: The Applications covered in the Wearable Neuromodulation Device Market report are Hospital, Clinic, Residential, Nursing Home, Others

What are the Type segmentation covered in the Wearable Neuromodulation Device Market report?

Ans: The Types covered in the Wearable Neuromodulation Device Market report are Head Mounted, Hand-worn, Leg-worn, Foot-worn

1 Wearable Neuromodulation Device Market Overview

1.1 Product Definition

1.2 Wearable Neuromodulation Device by Type

1.2.1 Global Wearable Neuromodulation Device Market Value Comparison by Type (2024 VS 2031)

1.2.2 Head Mounted

1.2.3 Hand-worn

1.2.4 Leg-worn

1.2.5 Foot-worn

1.3 Wearable Neuromodulation Device by Application

1.3.1 Global Wearable Neuromodulation Device Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Residential

1.3.5 Nursing Home

1.3.6 Others

1.4 Global Wearable Neuromodulation Device Market Size Estimates and Forecasts

1.4.1 Global Wearable Neuromodulation Device Revenue 2020-2031

1.4.2 Global Wearable Neuromodulation Device Sales 2020-2031

1.4.3 Global Wearable Neuromodulation Device Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Wearable Neuromodulation Device Market Competition by Manufacturers

2.1 Global Wearable Neuromodulation Device Sales Market Share by Manufacturers (2020-2025)

2.2 Global Wearable Neuromodulation Device Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Wearable Neuromodulation Device Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Wearable Neuromodulation Device, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Wearable Neuromodulation Device, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Wearable Neuromodulation Device, Product Type & Application

2.7 Global Key Manufacturers of Wearable Neuromodulation Device, Date of Enter into This Industry

2.8 Global Wearable Neuromodulation Device Market Competitive Situation and Trends

2.8.1 Global Wearable Neuromodulation Device Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Wearable Neuromodulation Device Players Market Share by Revenue

2.8.3 Global Wearable Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Wearable Neuromodulation Device Market Scenario by Region

3.1 Global Wearable Neuromodulation Device Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Wearable Neuromodulation Device Sales by Region: 2020-2031

3.2.1 Global Wearable Neuromodulation Device Sales by Region: 2020-2025

3.2.2 Global Wearable Neuromodulation Device Sales by Region: 2026-2031

3.3 Global Wearable Neuromodulation Device Revenue by Region: 2020-2031

3.3.1 Global Wearable Neuromodulation Device Revenue by Region: 2020-2025

3.3.2 Global Wearable Neuromodulation Device Revenue by Region: 2026-2031

3.4 North America Wearable Neuromodulation Device Market Facts & Figures by Country

3.4.1 North America Wearable Neuromodulation Device Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Wearable Neuromodulation Device Sales by Country (2020-2031)

3.4.3 North America Wearable Neuromodulation Device Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Wearable Neuromodulation Device Market Facts & Figures by Country

3.5.1 Europe Wearable Neuromodulation Device Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Wearable Neuromodulation Device Sales by Country (2020-2031)

3.5.3 Europe Wearable Neuromodulation Device Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Wearable Neuromodulation Device Market Facts & Figures by Region

3.6.1 Asia Pacific Wearable Neuromodulation Device Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Wearable Neuromodulation Device Sales by Region (2020-2031)

3.6.3 Asia Pacific Wearable Neuromodulation Device Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Wearable Neuromodulation Device Market Facts & Figures by Country

3.7.1 Latin America Wearable Neuromodulation Device Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Wearable Neuromodulation Device Sales by Country (2020-2031)

3.7.3 Latin America Wearable Neuromodulation Device Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Wearable Neuromodulation Device Market Facts & Figures by Country

3.8.1 Middle East and Africa Wearable Neuromodulation Device Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Wearable Neuromodulation Device Sales by Country (2020-2031)

3.8.3 Middle East and Africa Wearable Neuromodulation Device Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Wearable Neuromodulation Device Sales by Type (2020-2031)

4.1.1 Global Wearable Neuromodulation Device Sales by Type (2020-2025)

4.1.2 Global Wearable Neuromodulation Device Sales by Type (2026-2031)

4.1.3 Global Wearable Neuromodulation Device Sales Market Share by Type (2020-2031)

4.2 Global Wearable Neuromodulation Device Revenue by Type (2020-2031)

4.2.1 Global Wearable Neuromodulation Device Revenue by Type (2020-2025)

4.2.2 Global Wearable Neuromodulation Device Revenue by Type (2026-2031)

4.2.3 Global Wearable Neuromodulation Device Revenue Market Share by Type (2020-2031)

4.3 Global Wearable Neuromodulation Device Price by Type (2020-2031)

5 Segment by Application

5.1 Global Wearable Neuromodulation Device Sales by Application (2020-2031)

5.1.1 Global Wearable Neuromodulation Device Sales by Application (2020-2025)

5.1.2 Global Wearable Neuromodulation Device Sales by Application (2026-2031)

5.1.3 Global Wearable Neuromodulation Device Sales Market Share by Application (2020-2031)

5.2 Global Wearable Neuromodulation Device Revenue by Application (2020-2031)

5.2.1 Global Wearable Neuromodulation Device Revenue by Application (2020-2025)

5.2.2 Global Wearable Neuromodulation Device Revenue by Application (2026-2031)

5.2.3 Global Wearable Neuromodulation Device Revenue Market Share by Application (2020-2031)

5.3 Global Wearable Neuromodulation Device Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Nexalin

6.1.1 Nexalin Company Information

6.1.2 Nexalin Description and Business Overview

6.1.3 Nexalin Wearable Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Nexalin Wearable Neuromodulation Device Product Portfolio

6.1.5 Nexalin Recent Developments/Updates

6.2 Cefaly

6.2.1 Cefaly Company Information

6.2.2 Cefaly Description and Business Overview

6.2.3 Cefaly Wearable Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Cefaly Wearable Neuromodulation Device Product Portfolio

6.2.5 Cefaly Recent Developments/Updates

6.3 Theranica Bio-Electronics Ltd.

6.3.1 Theranica Bio-Electronics Ltd. Company Information

6.3.2 Theranica Bio-Electronics Ltd. Description and Business Overview

6.3.3 Theranica Bio-Electronics Ltd. Wearable Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Theranica Bio-Electronics Ltd. Wearable Neuromodulation Device Product Portfolio

6.3.5 Theranica Bio-Electronics Ltd. Recent Developments/Updates

6.4 Neurolief Inc.

6.4.1 Neurolief Inc. Company Information

6.4.2 Neurolief Inc. Description and Business Overview

6.4.3 Neurolief Inc. Wearable Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Neurolief Inc. Wearable Neuromodulation Device Product Portfolio

6.4.5 Neurolief Inc. Recent Developments/Updates

6.5 eNeura Inc.

6.5.1 eNeura Inc. Company Information

6.5.2 eNeura Inc. Description and Business Overview

6.5.3 eNeura Inc. Wearable Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)

6.5.4 eNeura Inc. Wearable Neuromodulation Device Product Portfolio

6.5.5 eNeura Inc. Recent Developments/Updates

6.6 Avation Medical

6.6.1 Avation Medical Company Information

6.6.2 Avation Medical Description and Business Overview

6.6.3 Avation Medical Wearable Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Avation Medical Wearable Neuromodulation Device Product Portfolio

6.6.5 Avation Medical Recent Developments/Updates

6.7 NeuroMetrix

6.7.1 NeuroMetrix Company Information

6.7.2 NeuroMetrix Description and Business Overview

6.7.3 NeuroMetrix Wearable Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)

6.7.4 NeuroMetrix Wearable Neuromodulation Device Product Portfolio

6.7.5 NeuroMetrix Recent Developments/Updates

6.8 Softeq Development

6.8.1 Softeq Development Company Information

6.8.2 Softeq Development Description and Business Overview

6.8.3 Softeq Development Wearable Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Softeq Development Wearable Neuromodulation Device Product Portfolio

6.8.5 Softeq Development Recent Developments/Updates

6.9 Cala Health, Inc.

6.9.1 Cala Health, Inc. Company Information

6.9.2 Cala Health, Inc. Description and Business Overview

6.9.3 Cala Health, Inc. Wearable Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Cala Health, Inc. Wearable Neuromodulation Device Product Portfolio

6.9.5 Cala Health, Inc. Recent Developments/Updates

6.10 Neurotherapeutics Ltd

6.10.1 Neurotherapeutics Ltd Company Information

6.10.2 Neurotherapeutics Ltd Description and Business Overview

6.10.3 Neurotherapeutics Ltd Wearable Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Neurotherapeutics Ltd Wearable Neuromodulation Device Product Portfolio

6.10.5 Neurotherapeutics Ltd Recent Developments/Updates

6.11 BlueWind Medical

6.11.1 BlueWind Medical Company Information

6.11.2 BlueWind Medical Description and Business Overview

6.11.3 BlueWind Medical Wearable Neuromodulation Device Sales, Revenue and Gross Margin (2020-2025)

6.11.4 BlueWind Medical Wearable Neuromodulation Device Product Portfolio

6.11.5 BlueWind Medical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Wearable Neuromodulation Device Industry Chain Analysis

7.2 Wearable Neuromodulation Device Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Wearable Neuromodulation Device Production Mode & Process Analysis

7.4 Wearable Neuromodulation Device Sales and Marketing

7.4.1 Wearable Neuromodulation Device Sales Channels

7.4.2 Wearable Neuromodulation Device Distributors

7.5 Wearable Neuromodulation Device Customer Analysis

8 Wearable Neuromodulation Device Market Dynamics

8.1 Wearable Neuromodulation Device Industry Trends

8.2 Wearable Neuromodulation Device Market Drivers

8.3 Wearable Neuromodulation Device Market Challenges

8.4 Wearable Neuromodulation Device Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Nexalin

Cefaly

Theranica Bio-Electronics Ltd.

Neurotherapeutics Ltd

BlueWind Medical

List of Tables

Table 1. Global Wearable Neuromodulation Device Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Wearable Neuromodulation Device Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Wearable Neuromodulation Device Market Competitive Situation by Manufacturers in 2024

Table 4. Global Wearable Neuromodulation Device Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Wearable Neuromodulation Device Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Wearable Neuromodulation Device Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Wearable Neuromodulation Device Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Wearable Neuromodulation Device Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Wearable Neuromodulation Device, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Wearable Neuromodulation Device, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Wearable Neuromodulation Device, Product Type & Application

Table 12. Global Key Manufacturers of Wearable Neuromodulation Device, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Wearable Neuromodulation Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Wearable Neuromodulation Device as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Wearable Neuromodulation Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Wearable Neuromodulation Device Sales by Region (2020-2025) & (K Units)

Table 18. Global Wearable Neuromodulation Device Sales Market Share by Region (2020-2025)

Table 19. Global Wearable Neuromodulation Device Sales by Region (2026-2031) & (K Units)

Table 20. Global Wearable Neuromodulation Device Sales Market Share by Region (2026-2031)

Table 21. Global Wearable Neuromodulation Device Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Wearable Neuromodulation Device Revenue Market Share by Region (2020-2025)

Table 23. Global Wearable Neuromodulation Device Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Wearable Neuromodulation Device Revenue Market Share by Region (2026-2031)

Table 25. North America Wearable Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Wearable Neuromodulation Device Sales by Country (2020-2025) & (K Units)

Table 27. North America Wearable Neuromodulation Device Sales by Country (2026-2031) & (K Units)

Table 28. North America Wearable Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Wearable Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Wearable Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Wearable Neuromodulation Device Sales by Country (2020-2025) & (K Units)

Table 32. Europe Wearable Neuromodulation Device Sales by Country (2026-2031) & (K Units)

Table 33. Europe Wearable Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Wearable Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Wearable Neuromodulation Device Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Wearable Neuromodulation Device Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Wearable Neuromodulation Device Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Wearable Neuromodulation Device Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Wearable Neuromodulation Device Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Wearable Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Wearable Neuromodulation Device Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Wearable Neuromodulation Device Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Wearable Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Wearable Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Wearable Neuromodulation Device Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Wearable Neuromodulation Device Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Wearable Neuromodulation Device Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Wearable Neuromodulation Device Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Wearable Neuromodulation Device Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Wearable Neuromodulation Device Sales (K Units) by Type (2020-2025)

Table 51. Global Wearable Neuromodulation Device Sales (K Units) by Type (2026-2031)

Table 52. Global Wearable Neuromodulation Device Sales Market Share by Type (2020-2025)

Table 53. Global Wearable Neuromodulation Device Sales Market Share by Type (2026-2031)

Table 54. Global Wearable Neuromodulation Device Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Wearable Neuromodulation Device Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Wearable Neuromodulation Device Revenue Market Share by Type (2020-2025)

Table 57. Global Wearable Neuromodulation Device Revenue Market Share by Type (2026-2031)

Table 58. Global Wearable Neuromodulation Device Price (US$/Unit) by Type (2020-2025)

Table 59. Global Wearable Neuromodulation Device Price (US$/Unit) by Type (2026-2031)

Table 60. Global Wearable Neuromodulation Device Sales (K Units) by Application (2020-2025)

Table 61. Global Wearable Neuromodulation Device Sales (K Units) by Application (2026-2031)

Table 62. Global Wearable Neuromodulation Device Sales Market Share by Application (2020-2025)

Table 63. Global Wearable Neuromodulation Device Sales Market Share by Application (2026-2031)

Table 64. Global Wearable Neuromodulation Device Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Wearable Neuromodulation Device Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Wearable Neuromodulation Device Revenue Market Share by Application (2020-2025)

Table 67. Global Wearable Neuromodulation Device Revenue Market Share by Application (2026-2031)

Table 68. Global Wearable Neuromodulation Device Price (US$/Unit) by Application (2020-2025)

Table 69. Global Wearable Neuromodulation Device Price (US$/Unit) by Application (2026-2031)

Table 70. Nexalin Company Information

Table 71. Nexalin Description and Business Overview

Table 72. Nexalin Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Nexalin Wearable Neuromodulation Device Product

Table 74. Nexalin Recent Developments/Updates

Table 75. Cefaly Company Information

Table 76. Cefaly Description and Business Overview

Table 77. Cefaly Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Cefaly Wearable Neuromodulation Device Product

Table 79. Cefaly Recent Developments/Updates

Table 80. Theranica Bio-Electronics Ltd. Company Information

Table 81. Theranica Bio-Electronics Ltd. Description and Business Overview

Table 82. Theranica Bio-Electronics Ltd. Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Theranica Bio-Electronics Ltd. Wearable Neuromodulation Device Product

Table 84. Theranica Bio-Electronics Ltd. Recent Developments/Updates

Table 85. Neurolief Inc. Company Information

Table 86. Neurolief Inc. Description and Business Overview

Table 87. Neurolief Inc. Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Neurolief Inc. Wearable Neuromodulation Device Product

Table 89. Neurolief Inc. Recent Developments/Updates

Table 90. eNeura Inc. Company Information

Table 91. eNeura Inc. Description and Business Overview

Table 92. eNeura Inc. Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. eNeura Inc. Wearable Neuromodulation Device Product

Table 94. eNeura Inc. Recent Developments/Updates

Table 95. Avation Medical Company Information

Table 96. Avation Medical Description and Business Overview

Table 97. Avation Medical Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Avation Medical Wearable Neuromodulation Device Product

Table 99. Avation Medical Recent Developments/Updates

Table 100. NeuroMetrix Company Information

Table 101. NeuroMetrix Description and Business Overview

Table 102. NeuroMetrix Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. NeuroMetrix Wearable Neuromodulation Device Product

Table 104. NeuroMetrix Recent Developments/Updates

Table 105. Softeq Development Company Information

Table 106. Softeq Development Description and Business Overview

Table 107. Softeq Development Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Softeq Development Wearable Neuromodulation Device Product

Table 109. Softeq Development Recent Developments/Updates

Table 110. Cala Health, Inc. Company Information

Table 111. Cala Health, Inc. Description and Business Overview

Table 112. Cala Health, Inc. Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Cala Health, Inc. Wearable Neuromodulation Device Product

Table 114. Cala Health, Inc. Recent Developments/Updates

Table 115. Neurotherapeutics Ltd Company Information

Table 116. Neurotherapeutics Ltd Description and Business Overview

Table 117. Neurotherapeutics Ltd Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Neurotherapeutics Ltd Wearable Neuromodulation Device Product

Table 119. Neurotherapeutics Ltd Recent Developments/Updates

Table 120. BlueWind Medical Company Information

Table 121. BlueWind Medical Description and Business Overview

Table 122. BlueWind Medical Wearable Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. BlueWind Medical Wearable Neuromodulation Device Product

Table 124. BlueWind Medical Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Wearable Neuromodulation Device Distributors List

Table 128. Wearable Neuromodulation Device Customers List

Table 129. Wearable Neuromodulation Device Market Trends

Table 130. Wearable Neuromodulation Device Market Drivers

Table 131. Wearable Neuromodulation Device Market Challenges

Table 132. Wearable Neuromodulation Device Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Wearable Neuromodulation Device

Figure 2. Global Wearable Neuromodulation Device Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Wearable Neuromodulation Device Market Share by Type: 2024 & 2031

Figure 4. Head Mounted Product Picture

Figure 5. Hand-worn Product Picture

Figure 6. Leg-worn Product Picture

Figure 7. Foot-worn Product Picture

Figure 8. Global Wearable Neuromodulation Device Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Wearable Neuromodulation Device Market Share by Application: 2024 & 2031

Figure 10. Hospital

Figure 11. Clinic

Figure 12. Residential

Figure 13. Nursing Home

Figure 14. Others

Figure 15. Global Wearable Neuromodulation Device Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Wearable Neuromodulation Device Market Size (2020-2031) & (US$ Million)

Figure 17. Global Wearable Neuromodulation Device Sales (2020-2031) & (K Units)

Figure 18. Global Wearable Neuromodulation Device Average Price (US$/Unit) & (2020-2031)

Figure 19. Wearable Neuromodulation Device Report Years Considered

Figure 20. Wearable Neuromodulation Device Sales Share by Manufacturers in 2024

Figure 21. Global Wearable Neuromodulation Device Revenue Share by Manufacturers in 2024

Figure 22. Global 5 and 10 Largest Wearable Neuromodulation Device Players: Market Share by Revenue in Wearable Neuromodulation Device in 2024

Figure 23. Wearable Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 24. Global Wearable Neuromodulation Device Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 25. North America Wearable Neuromodulation Device Sales Market Share by Country (2020-2031)

Figure 26. North America Wearable Neuromodulation Device Revenue Market Share by Country (2020-2031)

Figure 27. United States Wearable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Canada Wearable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Europe Wearable Neuromodulation Device Sales Market Share by Country (2020-2031)

Figure 30. Europe Wearable Neuromodulation Device Revenue Market Share by Country (2020-2031)

Figure 31. Germany Wearable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. France Wearable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. U.K. Wearable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Italy Wearable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Russia Wearable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Asia Pacific Wearable Neuromodulation Device Sales Market Share by Region (2020-2031)

Figure 37. Asia Pacific Wearable Neuromodulation Device Revenue Market Share by Region (2020-2031)

Figure 38. China Wearable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Japan Wearable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. South Korea Wearable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. India Wearable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Australia Wearable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. China Taiwan Wearable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Southeast Asia Wearable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Wearable Neuromodulation Device Sales Market Share by Country (2020-2031)

Figure 46. Latin America Wearable Neuromodulation Device Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Wearable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Wearable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Wearable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Wearable Neuromodulation Device Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Wearable Neuromodulation Device Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Wearable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Wearable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. UAE Wearable Neuromodulation Device Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Wearable Neuromodulation Device by Type (2020-2031)

Figure 56. Global Revenue Market Share of Wearable Neuromodulation Device by Type (2020-2031)

Figure 57. Global Wearable Neuromodulation Device Price (US$/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Wearable Neuromodulation Device by Application (2020-2031)

Figure 59. Global Revenue Market Share of Wearable Neuromodulation Device by Application (2020-2031)

Figure 60. Global Wearable Neuromodulation Device Price (US$/Unit) by Application (2020-2031)

Figure 61. Wearable Neuromodulation Device Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions